TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 20.13

Change

-1.18 (-5.54)%

Market Cap

N/A

Volume

2.99M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

-0.63 (-0.69%)

USD 42.11B
TEM Tempus AI, Inc. Class A Common..

-1.82 (-3.43%)

USD 7.92B
HQY HealthEquity Inc

-1.17 (-1.46%)

USD 6.98B
RCM R1 RCM Inc

+0.01 (+0.07%)

USD 5.98B
WAY Waystar Holding Corp. Common S..

-0.07 (-0.26%)

USD 4.47B
GDRX Goodrx Holdings Inc

+0.13 (+1.88%)

USD 2.57B
BTSG BrightSpring Health Services, ..

+0.03 (+0.20%)

USD 2.52B
PRVA Privia Health Group Inc

+0.16 (+0.91%)

USD 2.16B
PINC Premier Inc

+0.07 (+0.36%)

USD 2.00B
OMCL Omnicell Inc

-0.08 (-0.19%)

USD 1.98B

ETFs Containing TXG

ARKG:LSE ARK Genomic Revolution UC.. 4.13 % 0.00 %

+0.03 (+0.74%)

USD 2.96M
ARKG 4.08 % 0.75 %

N/A

N/A
ARCG:LSE ARK Genomic Revolution UC.. 4.04 % 0.00 %

+4.30 (+0.74%)

USD 3.03M
SGDM Sprott Gold Miners ETF 3.93 % 0.57 %

-0.16 (0.74%)

USD 0.28B
FDTS First Trust Developed Mar.. 0.00 % 0.80 %

-0.01 (0.74%)

USD 8.89M
PZC:CA 0.00 % 0.67 %

N/A

N/A
GOAU U.S. Global GO GOLD and P.. 0.00 % 0.60 %

-0.05 (0.74%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -64.03% 13% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.03% 13% F 11% F
Trailing 12 Months  
Capital Gain -49.37% 38% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.37% 38% F 17% F
Trailing 5 Years  
Capital Gain -60.87% 35% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.87% 30% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain 8.39% N/A N/A 64% D
Dividend Return 8.39% N/A N/A 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.85% N/A N/A 22% F
Risk Adjusted Return 10.77% N/A N/A 47% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike